Xyda Pharmaceutical Private Limited
About Xyda Pharmaceutical Private Limited
Data last updated:
Xyda Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC286736. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abhishek Deepak Thakkar and Jatin Deepak Thakkar.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 3 Lake Road Opp. Krishna Cinema Near Bhandup Police Station, Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2020, the company reported a revenue of ₹36.79 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net profit of ₹10,483 (net margin 0.3%) and EBITDA of ₹23,094 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 142% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Xyda Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3 Lake Road Opp. Krishna Cinema Near Bhandup Police Station, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xyda Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Xyda Pharmaceutical Private Limited
FY 2021 filings availableXyda Pharmaceutical Private Limited reported revenue of ₹36.79 Lakh (down 68% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 68% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 142%. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹36.79 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹23,094 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹10,483 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.6% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Xyda Pharmaceutical Private Limited, buy the company report.
Board of directors of Xyda Pharmaceutical Private Limited
Xyda Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Deepak Thakkar Also directs: D&L Commodities LLP | Director | 13 Oct 2016 | 10 Years 0 Months | Current |
| Jatin Deepak Thakkar | Director | 13 Oct 2016 | 10 Years 0 Months | Current |
| Jay Ashish Salia | Director | 13 Oct 2016 | 10 Years 0 Months | Current |
| Siddhanth Sudhakar Sharma Also directs: Junkie Eliminators India Private Limited | Director | 13 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Xyda Pharmaceutical Private Limited is audited by SALIYA ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SALIYA ASSOCIATES | FY 2019 | 115162W |
Shareholding
The shareholding of Xyda Pharmaceutical Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Xyda Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xyda Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xyda Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xyda Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Xyda Pharmaceutical Private Limited, buy the company report.
Recent activity
Xyda Pharmaceutical Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Abhishek Deepak Thakkar was appointed as Director on 13 Oct 2016.
Frequently asked questions
Xyda Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 October 2016 (10+ years old) and is registered under CIN U74999MH2016PTC286736.
Xyda Pharmaceutical has 4 current directors:
- Abhishek Deepak Thakkar - Director
- Jatin Deepak Thakkar - Director
- Jay Ashish Salia - Director
- Siddhanth Sudhakar Sharma - Director
The latest financial statements of Xyda Pharmaceutical on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
No. Xyda Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Xyda Pharmaceutical is U74999MH2016PTC286736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xyda Pharmaceutical was incorporated on 13 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Abhishek Deepak Thakkar was appointed as Director on 13 Oct 2016. Jatin Deepak Thakkar was appointed as Director on 13 Oct 2016. Jay Ashish Salia was appointed as Director on 13 Oct 2016. Xyda Pharmaceutical has 4 board changes on record in total.
The registered office of Xyda Pharmaceutical is at 3 Lake Road Opp. Krishna Cinema Near Bhandup Police Station, Mumbai, Maharashtra, India – 400078.
Xyda Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Xyda Pharmaceutical is compliant as of 18 September 2026. The company is actively filing with the Registrar of Companies.